프로테옴텍은 자사의 신제품과 혁신적인 기술을 세계시장에 홍보하기위하여 2015년 10월 14~17일 서울 코엑스에서 열린 세계 알러지 학회 2015 에 참석 하였다.

ProteomeTech is a biotech company developing immuno-diagnostic products and providing
proteomics-based R&D services.
We have accumulated proteomics-related technologies since 2000.

ProteomeTech has several innovative IVD products; PROTIA Allergy-Q, allergy test detecting
up to 64 allergies in one panel; ImmuneCheck IgG, Human IgG test adopting our own
Q-Rapid Technology can get semi-quantitative results; DoubleCheck, pregnancy test with
Q-Rapid Technology makes more accurate results possible.

PRODUCTS

up to 64 detecting lines in one plate!

-Model:

• PROTIA Allergy-Q Inhalant panel/Food panel/Atopy panel
• PROTIA Allergy-Q 64 Food panel/Inhalant panel

-Description:

• Multiplex, semi-quantitative detection of allergen-specific IgE in human serum or plasma
• 44 or 60 allergens test in a single panel
• Small sample volume: 50 μL
• Time for a test run: approx. 2.5 hours
• Internal calibration lines
• Concordance with ImmunoCap: 96%
• ISO13485, CE certificate
• associated immunoblot devices: Q-Scan(manual), Q-Station(all automation)

-PLA(Paralle Lines Array) Technology

Put more marker lines in a smaller chip by parallel line array
- biochip-assays more efficient & convenient
- Applicable to many kinds of biochip products using line-type blotting

Now with this innovative rapid kit, hIgG level check is fast and easy!

-Model: ImmuneCheck IgG
ImmuneCheck IgG_Lab

​

-Description:

• Quantitative Rapid test of total IgG for general immunity check-up
• Sample type: Whole blood, Plasma or Serum
• Sample Volume: 2~5 uL
• Assay Time: 20 min
• Good agreement with a Standard Method (Roche Cobas Integra 800)
• Detecting human IgG level 0.12~4000mg/dL
• CE, ISO13485 certificate

-Q-Rapid AD(Quantitative Rapid Test Technology with
Alternative Detection Lines):

This technology overcomes the hook effect by having two assay method lines
(sandwich immunoassay line and competitive immunoassay line) in a single test.
It also makes quantitative detection possible for rapid kit. ProteomeTech owned, patent applied.